Certara, Inc. (CERT)
NASDAQ: CERT · Real-Time Price · USD
5.46
+0.05 (0.92%)
Apr 6, 2026, 4:00 PM EDT - Market closed
Certara Revenue
In the year 2025, Certara had annual revenue of $418.84M with 8.75% growth. Certara had revenue of $103.65M in the quarter ending December 31, 2025, with 3.28% growth.
Revenue (ttm)
$418.84M
Revenue Growth
+8.75%
P/S Ratio
2.00
Revenue / Employee
$265,760
Employees
1,576
Market Cap
837.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 418.84M | 33.69M | 8.75% |
| Dec 31, 2024 | 385.15M | 30.81M | 8.70% |
| Dec 31, 2023 | 354.34M | 18.69M | 5.57% |
| Dec 31, 2022 | 335.64M | 49.54M | 17.32% |
| Dec 31, 2021 | 286.10M | 42.57M | 17.48% |
| Dec 31, 2020 | 243.53M | 35.02M | 16.79% |
| Dec 31, 2019 | 208.51M | 44.79M | 27.36% |
| Dec 31, 2018 | 163.72M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teladoc Health | 2.53B |
| Omnicell | 1.18B |
| GoodRx Holdings | 796.85M |
| Phreesia | 480.59M |
| HealthStream | 304.06M |
| Omada Health | 260.21M |
| Schrödinger | 255.87M |
| Weave Communications | 239.02M |
CERT News
- 5 weeks ago - Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib - GlobeNewsWire
- 5 weeks ago - Certara to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance - GlobeNewsWire
- 2 months ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Benzinga
- 2 months ago - Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025 - GlobeNewsWire
- 3 months ago - Tax-related selling could set up these 11 stocks for big gains early in 2026 - Market Watch
- 4 months ago - Certara Appoints Jon Resnick as Chief Executive Officer - GlobeNewsWire
- 5 months ago - Certara Reports Third Quarter 2025 Financial Results - GlobeNewsWire